Bisphosphonate-Induced Osteonecrosis of the Jaws, Bone Markers, and a Hypothesized Candidate Gene
- 1 January 2009
- journal article
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 67 (1) , 159-161
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jawsOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2008
- Atrial fibrillation: evidence for genetically determined diseaseCurrent Opinion in Cardiology, 2008
- Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureNew England Journal of Medicine, 2007
- The human disease networkProceedings of the National Academy of Sciences, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 2007
- Torg Syndrome Is Caused by Inactivating Mutations in MMP2 and Is Allelic to NAO and Winchester SyndromeJournal of Bone and Mineral Research, 2007
- Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk FactorsJournal of Clinical Oncology, 2005
- Osteonecrosis of the Jaw and BisphosphonatesNew England Journal of Medicine, 2005
- Bisphosphonate‐associated osteonecrosis of mandibular and maxillary boneCancer, 2005
- Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2Clinical Genetics, 2005